---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-003237"
form_type: "8-K"
ticker: "OGEN"
cik: "0001174940"
company_name: "ORAGENICS INC"
filed_at: "2026-01-22T23:59:59+00:00"
generated_at: "2026-05-16T08:42:23.422087+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Oragenics extends ATM equity distribution agreement with Dawson James

## Summary
- On January 22, 2026, Oragenics amended its at-the-market sales agreement with Dawson James Securities.
- The amendment extends the agreement term until all shares are sold or the shelf registration expires.
- No other terms of the original October 11, 2024 agreement were modified.
- The ATM facility allows the company to sell common stock from time to time on NYSE American.

## SEC filing metadata
- accession: 0001493152-26-003237
- form_type: 8-K
- ticker: OGEN
- cik: 0001174940
- company_name: ORAGENICS INC
- filed_at: 2026-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1174940/000149315226003237/0001493152-26-003237-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1174940/000149315226003237/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-003237
- JSON: https://secwatch.observer/filing/0001493152-26-003237.json
- Plain text: https://secwatch.observer/filing/0001493152-26-003237.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.